Related Experiment Video
Updated: May 2, 2026
05:17
Author Spotlight: Scope of LE-ULBD as a Safe, Effective, and Minimally Invasive Approach to Treat Lumbar Spinal Stenosis
Published on: February 9, 2024
1.7K
In-office, multisinus balloon dilation: 1-Year outcomes from a prospective, multicenter, open label trial
James Gould1, Ian Alexander, Edward Tomkin
1St. Louis Sinus Center, St. Louis, Missouri, USA.
American Journal of Rhinology & Allergy
|March 7, 2014
Summary
Office-based multisinus balloon dilation significantly improved sinonasal symptoms and reduced healthcare use for a full year. This safe and effective procedure offers sustained relief with minimal complications.
Area of Science:
- Otolaryngology
- Minimally Invasive Surgery
Background:
- Chronic or recurrent acute rhinosinusitis affects many adults.
- Current treatments may not provide adequate long-term relief.
Purpose of the Study:
- To assess 1-year changes in sinonasal symptoms and healthcare utilization.
- Evaluate the efficacy and safety of office-based multisinus balloon dilation.
Main Methods:
- Prospective, multicenter study of adults with chronic rhinosinusitis.
- Office-based balloon dilation of sinuses under local anesthesia.
- Symptom assessment using Sino-Nasal Outcome Test (SNOT-20) and Rhinosinusitis Symptom Inventory (RSI).
Main Results:
- 98.1% technical success rate with good procedure tolerance.
- Significant, sustained improvement in SNOT-20 and RSI scores at 1 year (p < 0.0001).
- Reduced acute sinus infections, antibiotic use, and physician visits by 2.3, 2.4, and 3.0, respectively (p < 0.0001).
Conclusions:
- In-office multisinus balloon dilation is safe, effective, and well-tolerated.
- Sustained symptom relief and reduced healthcare burden observed through 1 year.
- Low revision surgery rate (1.3%) indicates a favorable safety profile.
